The 1-year composite endpoint showed a numerical trend favoring TAVR over CASS in both ICM and NICM.
← all excerpts
Ischemic vs. Nonischemic Cardiomyopathy in TAVR for Moderate Aortic Stenosis: A TAVR UNLOAD Sub Analysis.
1
—
—
The 1-year composite endpoint showed a numerical trend favoring TAVR over CASS in both ICM and NICM.